Brian G. Feagan, MD
Brian G. Feagan, MD is a specialist in Internal Medicine with training in Clinical Epidemiology and Gastroenterology. His research interest has been in the design and implementation of randomized controlled trials.
His most significant research contributions relate to the findings from several multi-center clinical trials in which new therapeutics for the treatment of inflammatory bowel disease, in particular the use of immunosuppressants in patients with Crohn’s disease, have been identified.
Dr. Feagan is interested in the evaluation of Health Related Quality of Life (HRQL) and has performed research on the operating properties of HRQL instruments. He is also interested in the assessment of health utilities in patients with Crohn’s disease and other chronic illnesses. These assessments are performed from three different perspectives – that of the patients, the physicians, and the public. Findings from these research studies will be important for the interpretation of cost-utility models.
A more recent research interest of Dr. Feagan is the application of cluster randomization in the evaluation of health policies. This methodology is well-suited for the assessment of the effectiveness of treatment programs such as a care path for disease management. This type of research is highly relevant to healthcare providers who are responsible for the development and endorsement of comprehensive health management programs.